The report "Europe Veterinary Castration Market By Product Type (Immunocastration Vaccines, Hormonal Implants), Animal Type (Companion Dogs, Stray Dogs, Companion Cats, Stray Cats, Swine), End User (Veterinary Clinics, Veterinary Hospitals, NGOs) - Forecast to 2032 " The Europe veterinary castration market is projected to reach USD 68.2 million by 2032 from USD 45.6 million in 2026, at a CAGR of 6.9% during the forecast period.
Browse 50 market data Tables and 60 Figures spread through 200 Pages and in-depth TOC on "Europe Veterinary Castration Market By Product Type (Immunocastration Vaccines, Hormonal Implants), Animal Type (Companion Dogs, Stray Dogs, Companion Cats, Stray Cats, Swine), End User (Veterinary Clinics, Veterinary Hospitals, NGOs) - Forecast to 2032 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-veterinary-castration-market-246619807.html
By product type, the hormonal implants segment held the largest market share in 2025.
By product type, hormonal implants accounted for the largest share of the European veterinary castration market in 2025, supported by their extensive use in companion animals, their long-lasting and reversible effects, and the growing preference among veterinarians for minimally invasive and convenient alternatives to surgery.
By animal type, dogs held the largest share of the Europe veterinary castration market in 2025.
By animal type, dogs accounted for the largest share of the Europe veterinary castration market in 2025, supported by high ownership rates, an increasing focus on population management, and a growing preference for non-invasive sterilization methods.
Germany is expected to hold the largest share of the Europe veterinary castration market throughout the forecast period.
Germany is likely to capture the majority of the Europe veterinary castration market share throughout the forecast period due to its large companion animal population, well-developed veterinary infrastructure, and strong adoption of advanced animal health solutions.
Some leading companies in the Europe veterinary castration market include Zoetis (US) and Virbac (France).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]